Arterial-cardiac destiffening following long-term antihypertensive treatment

American Journal of Hypertension

Volumn 24, Issue 10, 2011, Pages 1080-1086

  Tomiyama, Hirofumi ^a   Yoshida, Masanobu ^a   Yamada, Jiko ^a   Matsumoto, Chisa ^a   Odaira, Mari ^a   Shiina, Kazuki ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

arterial stiffness; blood pressure; cardiac diastolic function; hypertension; renin angiotensin system

Indexed keywords

AMLODIPINE; CANDESARTAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE;

AGED; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANKLE BRACHIAL INDEX; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; DIASTOLE; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; TETRAZOLES; VASCULAR STIFFNESS;

EID: 80052969422     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.109     Document Type: Article

References (37)

1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and metaanalysis. J Am Coll Cardiol 2010; 55:1318-1327.
2. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 2010; 74:24-33.
3. Adji A, O'Rourke MF, Namasivayam M. Arterial stiffness, its assessment, prognostic value, and implications for treatment. Am J Hypertens 2011; 24:5-17.
4. Mahmud A, Feely J. Arterial stiffness and the renin-angiotensin- aldosterone system. J Renin Angiotensin Aldosterone Syst 2004; 5:102-108. (Pubitemid 39406718)
5. Karalliedde J, Smith A, DeAngelis L, Mirenda V, Kandra A, Botha J, Ferber P, Viberti G. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension 2008; 51:1617-1623.
6. Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004; 17:1050-1055. (Pubitemid 39469329)
7. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, Thomas F, Pannier B, Asmar R, Zureik M, Safar M, Guize L. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105:1202-1207. (Pubitemid 34225821)
8. Tomiyama H, Yambe M, Yamada J, Motobe K, Koji Y, Yoshida M, Shiina K, Yamashina A. Discrepancy between improvement of insulin sensitivity and that of arterial endothelial function in patients receiving antihypertensive medication. J Hypertens 2007; 25:883-889. (Pubitemid 46398885)
9. Yambe M, Tomiyama H, Hirayama Y, Gulniza Z, Takata Y, Koji Y, Motobe K, Yamashina A. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 2004; 27:625-631. (Pubitemid 39534503)
10. McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clin Exp Pharmacol Physiol 2007; 34:665-671. (Pubitemid 46953116)
11. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943. (Pubitemid 40627836)
12. Desai AS, Mitchell GF, Fang JC, Creager MA. Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail 2009; 15:658-664.
13. Wang J, Nagueh SF. Current perspectives on cardiac function in patients with diastolic heart failure. Circulation 2009; 119:1146-1157.
14. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005; 46:185-193. (Pubitemid 40946512)
15. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourciée Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP; Valsartan In Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007; 369:2079-2087. (Pubitemid 46935945)
16. Almuntaser I, Mahmud A, Brown A, Murphy R, King G, Crean P, Feely J. Blood pressure control determines improvement in diastolic dysfunction in early hypertension. Am J Hypertens 2009; 22:1227-1231.
17. Japanese Society of Hypertension. Guidelines for the Management of Hypertension. 2004: pp 10-20. (In Japanese)
18. Japanese Society of Hypertension. Guidelines for the Management of Hypertension. 2004: pp 14-21. (In Japanese)
19. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14:45-50.
20. Deveroux RB, Reichech N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55:613-618.
21. Tomiyama H, Nishikawa E, Abe M, Nakagawa K, Fujiwara M, Yamamoto A, Yoshida H, Doba N. Carotid arterial distensibility is an important determinant of improvement in autonomic balance after successful coronary angioplasty. J Hypertens 2000; 18:1621-1628.
22. Tomiyama H, Hashimoto H, Tanaka H, Matsumoto C, Odaira M, Yamada J, Yoshida M, Shiina K, Nagata M, Yamashina A. Continuous smoking and progression of arterial stiffening: a prospective study. J Am Coll Cardiol 2010; 55:1979-1987.
23. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25:359-364. (Pubitemid 34752554)
24. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-992.
25. Ait-Oufella H, Collin C, Bozec E, Laloux B, Ong KT, Dufouil C, Boutouyrie P, Laurent S. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens 2010; 28:2336-2341.
26. Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, Tomiyama H, Yamashina A, Yasuda H, Sawayama T, Ozawa T. Comparison between carotidfemoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009; 27:2022-2027.
27. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351:9-13. (Pubitemid 28020159)
28. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105:595-601. (Pubitemid 34123434)
29. Blankenberg S, Zeller T, Saarela O, Havulinna AS, Kee F, Tunstall-Pedoe H, Kuulasmaa K, Yarnell J, Schnabel RB, Wild PS, Müzel TF, Lackner KJ, Tiret L, Evans A, Salomaa V; MORGAM Project. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010; 121:2388-2397.
30. Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T; Candesartan Antihypertensive Survival Evaluation in Japan Trial Group. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension 2008; 51:393-398. (Pubitemid 351159955)
31. Mitsunami K, Inoue S, Maeda K, Endoh S, Takahashi M, Okada M, Sugihara H, Kinoshita M. Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Cardiovasc Drugs Ther 1998; 12: 469-474. (Pubitemid 29002785)
32. Terpstra WF, May JF, Smit AJ, de Graeff PA, Havinga TK, van den Veur E, Schuurman FH, Meyboom-de Jong B, Crijns HJ. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial. J Hypertens 2001; 19:303-309. (Pubitemid 32116282)
33. Fagard RH, Celis H, Thijs L, Wouters S. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension 2009; 54:1084-1091.
34. Brilla CG, Rupp H, Funck R, Maisch B. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 1995; 16 Suppl O:107-109. (Pubitemid 26082358)
35. Ainscough JF, Drinkhill MJ, Sedo A, Turner NA, Brooke DA, Balmforth AJ, Ball SG. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc Res 2009; 81:592-600.
36. Seals DR, Desouza CA, Donato AJ, Tanaka H. Habitual exercise and arterial aging. J Appl Physiol 2008; 105:1323-1332.
37. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension 2011; 57:3-10.